Treat-to-Target in Inflammatory Bowel Diseases, What Is the Target and How Do We Treat?

Research output: Contribution to journalReview articlepeer-review

40 Scopus citations


Inflammatory bowel diseases, including Crohn disease (CD)and ulcerative colitis (UC), are chronic, progressive, immune-mediated inflammatory diseases of the gastrointestinal tract. Early therapy using a treat-to-target (T2T)approach, which implies identification of a pre-defined target, followed by optimization of therapy and regular monitoring until the goal is achieved is critical in preventing adverse long-term outcomes. In this review, the authors discuss the T2T guidance developed by the Selecting Therapeutic Targets in Inflammatory Bowel Disease committee, new evidence published on the role of various targets in CD and UC, as well as the real-world applicability of T2T.”

Original languageEnglish
Pages (from-to)421-436
Number of pages16
JournalGastrointestinal Endoscopy Clinics of North America
Issue number3
StatePublished - Jul 2019


  • Crohn's disease
  • Inflammatory bowel diseases
  • Long-term outcomes
  • Treat-to-target
  • Ulcerative colitis


Dive into the research topics of 'Treat-to-Target in Inflammatory Bowel Diseases, What Is the Target and How Do We Treat?'. Together they form a unique fingerprint.

Cite this